Market revenue in 2023 | USD 5,912.0 million |
Market revenue in 2030 | USD 6,444.8 million |
Growth rate | 1.2% (CAGR from 2023 to 2030) |
Largest segment | Oseltamivir phosphate |
Fastest growing segment | Baloxavir Marboxil |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Peramivira, Zanamivir, Baloxavir Marboxil, Oseltamivir Phosphate |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to influenza treatment market will help companies and investors design strategic landscapes.
Oseltamivir phosphate was the largest segment with a revenue share of 27.6% in 2023. Horizon Databook has segmented the Global influenza treatment market based on peramivira, zanamivir, baloxavir marboxil, oseltamivir phosphate covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global influenza treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global influenza treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Treatment | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 2,302.4 | 2,338.8 | 2,170.4 | 2,339.1 | 2,414.2 | 2,453.0 | 2,490.8 | 2,522.1 | 2,548.0 | 2,580.2 | 2,607.2 | 2,635.3 | 2,666.7 | 1.2% |
Europe | 1,941.6 | 1,973.2 | 1,877.3 | 1,975.4 | 2,039.8 | 2,073.6 | 2,106.7 | 2,134.2 | 2,157.2 | 2,185.5 | 2,209.4 | 2,234.3 | 2,262.1 | 1.3% |
Asia Pacific | 659.5 | 672.2 | 641.3 | 676.8 | 700.9 | 714.6 | 728.1 | 739.7 | 749.9 | 761.9 | 772.5 | 783.5 | 795.5 | 1.5% |
Latin America | 351.2 | 357.3 | 340.2 | 358.3 | 370.3 | 376.8 | 383.1 | 388.5 | 393.0 | 398.5 | 403.3 | 408.2 | 413.6 | 1.3% |
MEA | 283.6 | 286.6 | 324.6 | 283.5 | 291.0 | 294.0 | 296.9 | 298.9 | 300.3 | 302.3 | 303.7 | 305.1 | 306.9 | 0.6% |
Overall | 5,538.3 | 5,628.0 | 5,353.8 | 5,633.1 | 5,816.2 | 5,912.0 | 6,005.6 | 6,083.3 | 6,148.4 | 6,228.5 | 6,296.0 | 6,366.3 | 6,444.8 | 1.2% |
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account